{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:51:56Z","timestamp":1789563116449,"version":"build-2803163510"},"reference-count":43,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Data are limited regarding the effectiveness and safety of generic velpatasvir plus sofosbuvir (<jats:styled-content style=\"fixed-case\">VEL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>) for hepatitis C virus (<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>) in patients with or without human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>) coinfection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the effectiveness and safety of generic<jats:styled-content style=\"fixed-case\">VEL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>\u2010based therapy for<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>infection in patients with or without<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>coinfection in Taiwan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixty\u2010nine<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010coinfected and 159<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010monoinfected patients receiving 12\u00a0weeks of generic<jats:styled-content style=\"fixed-case\">VEL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>with or without ribavirin (<jats:styled-content style=\"fixed-case\">RBV<\/jats:styled-content>) for<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>were prospectively enrolled. The anti\u2010viral responses and the adverse events (<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>s) were compared between the two groups. The characteristics potentially related to sustained virological response 12\u00a0weeks off therapy (<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content><jats:sub>12<\/jats:sub>) were analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content><jats:sub>12<\/jats:sub>was achieved in 67<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010coinfected patients (97.1%; 95%<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 90.0%\u201099.2%) and in 156<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010monoinfected patients (98.1%; 95%<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 94.6%\u201099.4%) receiving<jats:styled-content style=\"fixed-case\">VEL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>\u2010based therapy, respectively. The<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content><jats:sub>12<\/jats:sub>rates were comparable between<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010coinfected and<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010monoinfected patients, regardless of pre\u2010specified baseline characteristics. One hundred twenty\u2010two (53.5%) and seven (3.1%) patients had baseline resistance\u2010associated substitutions (<jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s) in<jats:styled-content style=\"fixed-case\">HCV NS<\/jats:styled-content>5A and<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5B regions, but the<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content><jats:sub>12<\/jats:sub>rates were not affected by the presence or absence of<jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s. One (1.4%) and five (3.1%) patients in the<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010coinfected and<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010monoinfected groups had serious<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>s. No patient died or discontinued treatment due to<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>s. The<jats:styled-content style=\"fixed-case\">eGFR<\/jats:styled-content>remained stable throughout the course of treatment in<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010coinfected patients receiving anti\u2010retroviral therapy containing tenofovir disoproxil fumarate (<jats:styled-content style=\"fixed-case\">TDF<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Generic<jats:styled-content style=\"fixed-case\">VEL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>\u2010based therapy is well\u2010tolerated and provides comparably high<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content><jats:sub>12<\/jats:sub>rates for<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>infection in patients with and without<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>coinfection.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.14647","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T17:56:26Z","timestamp":1523987786000},"page":"1690-1698","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection"],"prefix":"10.1111","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-9707","authenticated-orcid":false,"given":"C.\u2010H.","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"},{"name":"Department of Internal Medicine National Taiwan University Hospital Douliou Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010Y.","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-0993","authenticated-orcid":false,"given":"C.\u2010J.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"},{"name":"Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.\u2010H.","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u2010M.","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010C.","family":"Lo","sequence":"additional","affiliation":[{"name":"Centers for Disease Control Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.\u2010C.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.\u2010H.","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010C.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"},{"name":"Department of Microbiology National Taiwan University College of Medicine Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u2010M.","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Traumatology National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.\u2010C.","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.\u2010J.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"},{"name":"Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.\u2010S.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"},{"name":"Genomics Research, Center Academia Sinica Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-0836","authenticated-orcid":false,"given":"C.\u2010C.","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Department of Parasitology National Taiwan University College of Medicine Taipei Taiwan"},{"name":"Department of Medical Research China Medical University Hospital Taichung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"J.\u2010H.","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"},{"name":"Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan"},{"name":"Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.450"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30181-9"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00485-5"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.31.10.2679-2682.1993"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00604"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/380130"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.08.024"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M13-1829","article-title":"Hepatic decompensation in antiretroviral\u2010treated patients co\u2010infected with HIV and hepatitis C virus compared with hepatitis C virus\u2010monoinfected patients: a cohort study","volume":"160","author":"Lo Re V","year":"2014","journal-title":"Ann Intern Med"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7844"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis500"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512612"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512614"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix260"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13157"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32051-7"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9787-0"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.025"},{"key":"e_1_2_7_20_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2055-6640(20)30324-1","article-title":"High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C","volume":"3","author":"Hill A","year":"2017","journal-title":"J Virus Erad"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14428"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25033"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12870"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep17410"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03548-14"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13834"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.014"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx028"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1328"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501315"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503153"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00114-9"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2016.1145545"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13912"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176503"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27641"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu012"},{"key":"e_1_2_7_38_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S2055-6640(20)30286-7","article-title":"The complex legal and ethical issues related to generic medications. viral hepatitis: a case study","volume":"3","author":"Danta M","year":"2017","journal-title":"J Virus Erad"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.006"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.032"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613512"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702417"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.09.027"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.011"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.14647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.14647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T18:54:52Z","timestamp":1751568892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.14647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1111\/apt.14647"],"URL":"https:\/\/doi.org\/10.1111\/apt.14647","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"2017-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}